« Other than that, it's a fine product | Main | Failure is about to become an option in China »

August 31, 2007

Generic epo about to hit the market in Europe

Novartis wins the race to bet a generic version of epo approved in Europe. Truly a watershed day in biotech, in my view. Will we ever see generic epo in the US? That's the question...

Bloomberg.com: Germany

Novartis is first in a race among generic companies including Germany's Stada Arzneimittel AG to enter the $7 billion market dominated by Johnson & Johnson and Amgen Inc's branded versions of the drug. Sandoz sued U.S. regulators last year to win approval to copy the human growth hormone.

Posted by on August 31, 2007 at 10:06 AM in Money and Science, Pharmaceuticals and Biotechnology, Politics |

Comments

The comments to this entry are closed.